Literature DB >> 168490

Characterization of alpha1-antitrypsin in the inclusion bodies from the liver in alpha 1-antitrypsin deficiency.

J O Jeppsson, C Larsson, S Eriksson.   

Abstract

alpha1-antitrypsin was isolated from periodic acid-Schiff-positive inclusion bodies from the hepatocytes of patients with alpha1-antitrypsin deficiency and further purified to enable more detailed chemical analysis. Amino acid and cyanogen bromide fragmentation studies showed a close similarity between hepatic and serum (PiMM) antitrypsin in contrast to the carbohydrate analysis, which revealed markedly deficient glycosylation of hepatic antitrypsin. A complete lack of sialic acid and a relative deficiency of all other carbohydrate components could fully explain the difference of approximately 6000 daltons in molecular size between the two proteins. The accumulation of hepatic globules is probably related to the physical properties of the defective antitrypsin, which include marked insolubility and tendency toward aggregation. The results strongly suggest an abnormal amino acid sequence in the peptide chain of the deficient antitrypsin. The interference with glycosylation may be related to steric hindrance.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 168490     DOI: 10.1056/NEJM197509182931203

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  27 in total

1.  Molecular abnormality of human alpha1-antitrypsin variant (Pi-ZZ) associated with plasma activity deficiency.

Authors:  A Yoshida; J Lieberman; L Gaidulis; C Ewing
Journal:  Proc Natl Acad Sci U S A       Date:  1976-04       Impact factor: 11.205

2.  Isolation and characterization of alpha 1-antitrypsin in PAS-positive hepatic granules from rats with experimental alpha 1-antitrypsin deficiency.

Authors:  S Bolmer; J Kleinerman
Journal:  Am J Pathol       Date:  1986-05       Impact factor: 4.307

3.  [Glycoproteins: their biological and clinical significance. II (author's transl)].

Authors:  E Köttgen; C Bauer; W Reutter; W Gerok
Journal:  Klin Wochenschr       Date:  1979-03-01

4.  Immunohistochemical demonstration of alpha-1-antitrypsin in renal tubular epithelia in patients with or without alpha-1-antitrypsin deficiency.

Authors:  Y H Xu; S Ito; R L Peters
Journal:  J Tongji Med Univ       Date:  1986

5.  The cellular defect in alpha 1-proteinase inhibitor (alpha 1-PI) deficiency is expressed in human monocytes and in Xenopus oocytes injected with human liver mRNA.

Authors:  D H Perlmutter; R M Kay; F S Cole; T H Rossing; D Van Thiel; H R Colten
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

6.  [Prolonged jaundice by heterozygous alpha-1-antitrypsin-deficience? (author's transl)].

Authors:  D Karitzky; M Otto; J P Martin
Journal:  Klin Wochenschr       Date:  1977-12-01

Review 7.  Pharmacoperones as Novel Therapeutics for Diverse Protein Conformational Diseases.

Authors:  Ya-Xiong Tao; P Michael Conn
Journal:  Physiol Rev       Date:  2018-04-01       Impact factor: 37.312

8.  High-level production of biologically active human alpha 1-antitrypsin in Escherichia coli.

Authors:  M Courtney; A Buchwalder; L H Tessier; M Jaye; A Benavente; A Balland; V Kohli; R Lathe; P Tolstoshev; J P Lecocq
Journal:  Proc Natl Acad Sci U S A       Date:  1984-02       Impact factor: 11.205

9.  Synthesis of beta-hexosaminidase in cell-free translation and in intact fibroblasts: an insoluble precursor alpha chain in a rare form of Tay-Sachs disease.

Authors:  R L Proia; E F Neufeld
Journal:  Proc Natl Acad Sci U S A       Date:  1982-10       Impact factor: 11.205

10.  Purification of alpha-1-antitrypsin monomer by preparative electrophoresis.

Authors:  F Spada; G Candiano; C Sergi; G M Ghiggeri; F Callea; R Gusmano
Journal:  J Clin Pathol       Date:  1994-07       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.